Skip to main content
Article thumbnail
Location of Repository

Factores de riesgo y supervivencia libre de tumor en pacientes con trasplante renal de cadáver

By Ildefonso Lampreabe Gaztelu, Jesús María Orbe Lizundia, Jorge Virto Moreno, Francisco Javier Gainza Ríos, S. Zárraga, J. M. Urbizu, G. García and J. J. Amenábar

Abstract

[Background] There is an agreement in the fact that cancer incidence in transplant recipients increases at a rate disproportionately greater than in the general population. Several clinical studies have identified cancer risk factors, such as age, male gender, tobacco, UV radiation, viral infections, previous malignancies, intensity and duration of immunosuppressive therapies, HLA matches and time in waiting list.

OAI identifier:

Suggested articles

Citations

  1. 14. Lampreabe I, Amenabar JJ, Clinical characteristics in cyclosporine-treated and noncyclosporine treated adult renal cadaveric allograft recipients
  2. (2003). Análisis estadístico de la incidencia de cánceres "de novo" en pacientes trasplantados renales: una nueva metodología de estudio.
  3. (1996). Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
  4. (1997). Cancer risk after renal transplantation in japan.
  5. (1999). Cancer risk associated with ATG/OKT3 in renal transplantation. Transplantation Proc.,
  6. (2001). Causas de muerte en pacientes con trasplante renal En: Problemas Clínicos en el paciente Trasplantado (Coordinadores: V.Cuervas-Mons,
  7. (2001). Controlling the incidence of infection and malignancy by modifying immunosuppression.
  8. (1997). De novo cancers complicating renal transplantation: experience in the nordic countries.
  9. European best practice guidelines for renal transplantation,
  10. (1999). Gómez Ullate P . Síndromes linfoproliferativos en los receptores de
  11. (2000). Long-term survival in renal transplant recipients with graft function', Kidney Int
  12. (1998). Malignancies that ocurr in organ allograft recipients. Current opinion in Organ Transplantation
  13. (1997). Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proceedings,
  14. (2001). Malignancy after renal transplantation: analysis of incidence and risks factors in 1700 patients followed during 25-year period. In
  15. (2002). Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol,
  16. (2002). Malignancy after renal transplantation.
  17. (1995). Malignant disease in patients with long-term renal transplants.
  18. (1990). Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantation. Nephrology Dialysis Transplantation,
  19. (1997). p53 tumor suppressor gene protein expression in premalignat and malignant skin lesion of kidney transplant recipients.
  20. (2001). Presentación de cánceres en receptores trasplantados con órgano sólido. Nefrología,
  21. (1994). Proportional hazards tests and diagnostics based on weighted residuals.
  22. (1972). Regression models and life tables (with discussion).
  23. (1999). Risk factors for cancer in renal transplant recipients.
  24. (1998). Skin cancers in organ transplants recipients. Current Opinion in Organ Transplantation
  25. (1996). Tumors after renal transplantation.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.